| P50 | author | Claudiu T Supuran | Q28211545 |
| | Ahmed Elkamhawy | Q57012693 |
| P2093 | author name string | Eun Joo Roh | |
| | So Ha Lee | |
| | Wagdy M Eldehna | |
| | Mohamed A Abdelgawad | |
| | Silvia Bua | |
| | Mohammad M Al-Sanea | |
| | Sora Paik | |
| P2860 | cites work | Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste | Q27647390 |
| | Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency | Q27664906 |
| | Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases | Q27683603 |
| | Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 |
| | The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C | Q28646334 |
| | Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors | Q33629972 |
| | Designing of novel carbonic anhydrase inhibitors and activators. | Q34343296 |
| | Carbonic anhydrases: current state of the art, therapeutic applications and future prospects | Q34361209 |
| | Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms | Q91476816 |
| | Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors | Q93065311 |
| | Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents | Q93175629 |
| | SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX | Q93341111 |
| | Quinoline as a privileged scaffold in cancer drug discovery | Q37856342 |
| | Carbonic anhydrase inhibitors and activators for novel therapeutic applications | Q37909406 |
| | Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 |
| | (In)organic anions as carbonic anhydrase inhibitors | Q37970856 |
| | Structure-based drug discovery of carbonic anhydrase inhibitors | Q37999063 |
| | Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? | Q38011235 |
| | Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis | Q38020887 |
| | Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013). | Q38089120 |
| | Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review | Q38091452 |
| | Antiglaucoma carbonic anhydrase inhibitors: a patent review | Q38102786 |
| | A review on anticancer potential of bioactive heterocycle quinoline | Q38235172 |
| | Quinoline: a promising antitubercular target | Q38280178 |
| | The η-class carbonic anhydrases as drug targets for antimalarial agents | Q38286239 |
| | Acetazolamide for the treatment of idiopathic intracranial hypertension | Q38543994 |
| | Bacterial, fungal and protozoan carbonic anhydrases as drug targets. | Q38559435 |
| | How many carbonic anhydrase inhibition mechanisms exist? | Q38653464 |
| | 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation | Q38839891 |
| | Structure and function of carbonic anhydrases | Q38894649 |
| | Advances in structure-based drug discovery of carbonic anhydrase inhibitors | Q38991378 |
| | Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms. | Q39246954 |
| | Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors | Q41666673 |
| | Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors | Q42713573 |
| | Carbonic anhydrase inhibitors | Q43042271 |
| | Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid | Q46519336 |
| | Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects. | Q46697605 |
| | An Overview of the Bacterial Carbonic Anhydrases | Q47145746 |
| | Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? | Q47692161 |
| | Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors | Q47719833 |
| | Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays | Q47809412 |
| | Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators. | Q48000247 |
| | Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides | Q48017394 |
| | 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. | Q48030765 |
| | Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases. | Q48110370 |
| | Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor. | Q49332625 |
| | 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. | Q51094113 |
| | Carbonic anhydrase activators. | Q51767411 |
| | 2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering age | Q52596189 |
| | Carbonic Anhydrases and Metabolism. | Q52645009 |
| | Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species. | Q55611103 |
| | Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors | Q57279715 |
| | Quinoline and quinolone dimers and their biological activities: An overview | Q57814239 |
| | A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors | Q57911941 |
| | Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors | Q58700155 |
| | Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells | Q58855679 |
| | Carbonic Anhydrase Inhibitors: Clash with Ala65 as a Means for Designing Inhibitors with Low Affinity for the Ubiquitous Isozyme II, Exemplified by the Crystal Structure of the Topiramate Sulfamide Analogue† | Q58863277 |
| | Carbonic anhydrase inhibitors | Q58863345 |
| | A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology | Q84679919 |
| | Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines | Q88614584 |
| | Synthesis and pharmacological evaluation of pyrazolo[4,3-c]quinolinones as high affinity GABAA-R ligands and potential anxiolytics | Q89320179 |
| | Biomedical applications of prokaryotic carbonic anhydrases | Q89420700 |
| | Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies | Q90714675 |
| | Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018) | Q90735662 |
| | Green recipes to quinoline: A review | Q90800498 |
| | Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases | Q91269702 |
| | Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas | Q91453043 |
| | Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer | Q91467343 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 1457-1464 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamidesAQ3 as carbonic anhydrase isoforms I and II inhibitors | |
| P478 | volume | 34 | |